SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

259 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2021.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 54.1M shares of 56M outstanding shares and own 96.61% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.87M shares), VANGUARD GROUP INC (5.48M shares), ARMISTICE CAPITAL, LLC (3.32M shares), DIMENSIONAL FUND ADVISORS LP (2.28M shares), MACQUARIE GROUP LTD (2.14M shares), STATE STREET CORP (1.83M shares), LOOMIS SAYLES & CO L P (1.62M shares), GW&K Investment Management, LLC (1.62M shares), RENAISSANCE TECHNOLOGIES LLC (1.52M shares), and Stephens Investment Management Group LLC (1.25M shares).
This table shows the top 224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.